Circular dichroism in drug discovery and development: An abridged review

Analytical and Bioanalytical Chemistry

Volumn 398, Issue 1, 2010, Pages 155-166

  Bertucci, Carlo ^a   Pistolozzi, Marco ^a   De Simone, Angela ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bioanalytical methods; Chiral analysis; Circular dichroism; Drug protein interactions; Molecular recognition mechanism; Protein protein interactions

Indexed keywords

BIOANALYTICAL METHODS; CHIRAL ANALYSIS; CIRCULAR DICHROISM; DRUG-PROTEIN INTERACTIONS; MOLECULAR RECOGNITION MECHANISM; PROTEIN-PROTEIN INTERACTIONS;

CHEMICAL ANALYSIS; CHIRALITY; CIRCULAR DICHROISM SPECTROSCOPY; DICHROISM; ENANTIOMERS; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; PEPTIDES; STEREOCHEMISTRY;

DRUG INTERACTIONS;

DRUG;

CHEMISTRY; CIRCULAR DICHROISM; CONFORMATION; DRUG DEVELOPMENT; HUMAN; REVIEW; UTILIZATION REVIEW;

CIRCULAR DICHROISM; DRUG DISCOVERY; HUMANS; MOLECULAR CONFORMATION; PHARMACEUTICAL PREPARATIONS;

EID: 77955948805     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-3959-2     Document Type: Review

References (111)

1. Aboul-Enein HY, Wainer IW (eds) (1997) The impact of stereochemistry on drug development and use (Chemical Analysis Series). Wiley, New York
2. Ariens EJ (1984) Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 26:663-666
3. Nakanishi K, Berova N, Woody RW (eds)(1994) Circular dichroism: principles and applications. VCH, New York
4. GA Ascoli E Domenici C Bertucci 2006 Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism Chirality 18 9 667 679 10.1002/chir.20301 1:CAS:528:DC%2BD28Xpsl2gu7g%3D (Pubitemid 44408409)
5. Stephens PJ, Devlin FJ, Pan JJ (2008) The determination of the absolute configuration of chiral molecules using vibrational circular dichroism (VCD) spectroscopy. Chirality 20(5):643-663
6. M Urbanova 2009 Bioinspired interactions studied by vibrational circular dichroism Chirality 21 E215 E230 10.1002/chir.20803 1:CAS:528: DC%2BC3cXns12mtLg%3D
7. Bijvoet JM, Peerdeman AF, van Bommel AJ (1951) Determination of the absolute configuration of optically active compounds by means of X-rays. Nature 168:271-272
8. HD Flack 1983 On enantiomorph-polarity estimation Acta Crystallogr A 39 876 881 10.1107/S0108767383001762
9. A Cavalli A Bisi C Bertucci C Rosini A Paluszcak S Gobbi E Giorgio A Rampa F Belluti L Piazzi PW Valenti R Hartmann M Recanatini 2005 Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach J Med Chem 48 7282 7289 10.1021/jm058042r 1:CAS:528:DC%2BD2MXhtFalu77J (Pubitemid 41743641)
10. G Bringmann TAM Gulder M Reichert T Gulder 2008 The online assignment of the absolute configuration of natural products: HPLC-CD in combination with quantum chemical CD calculations Chirality 20 628 642 10.1002/chir.20557 1:CAS:528:DC%2BD1cXltlCjsbw%3D (Pubitemid 351656168)
11. Iwasa K, Takahashi T, Nishiyama Y, Moriyasu M, Sugiura M, Takeuchi A, Tode C, Tpkuda H, Takeda K (2008) Online structural elucidation of alkaloids and other constituents in crude extracts and cultured cells of Nandina domestica by combination of LC-MS/MS, LC-NMR. and LC-CD analyses. J Nat Prod 71:1376-1385
12. C Bertucci GLF Bonato BKB PS LT Okano G Mazzeo C Rosini 2010 Assignment of the absolute configuration at the sulfur atom of thioridazine metabolites by the analysis of their chiroptical properties: the case of thioridazine 2-sulfoxide J Pharm Biomed Anal 52 5 796 801 10.1016/j.jpba.2010.01.047 1:CAS:528:DC%2BC3cXksVamt70%3D
13. 1H NMR anisotropy Chirality 20 691 723 10.1002/chir.20478 1:CAS:528:DC%2BD1cXltlCjsbk%3D (Pubitemid 351656173)
14. Owen CP, Nicholls PJ, Smith HJ, Whomsley R (1999) Inhibition of aromatase (P450Arom) by some 1-(benzofuran-2-ylmethyl)imidazoles. J Pharm Pharmacol 51:427-433
15. M Recanatini A Cavalli P Valenti 2002 Nonsteroidal aromatase inhibitors: recent advances Med Res Rev 22 282 304 10.1002/med.10010 1:CAS:528: DC%2BD38XjslGru70%3D (Pubitemid 34415467)
16. M Recanatini 1996 Comparative molecular field analysis of non-steroidal aromatase inhibitors related to fadrozole J Comput Aided Mol Des 10 74 82 10.1007/BF00124467 1:CAS:528:DyaK28Xhs1ars78%3D
17. Mason SF (1962) Optical rotatory power. Quart Rev 17-20
18. Mason SF (1967) Theory II. Optical rotatory dispersion and circular dichroism in organic chemistry (Chap 4). Heyden and Son, London, p 71
19. Gottarelli G, Mason SF, Torre G (1971) The circular dichroism and absolute configuration of (+)-trans-stilbene oxide. J Chem Soc B 7:1349-1353
20. N Harada K Nakanishi 1972 The exciton chirality method and its application to configurational and conformational studies of natural products Acc Chem Res 5 257 263 10.1021/ar50056a001 1:CAS:528:DyaE38XltVSmtrY%3D
21. Mason SF (1982) Molecular optical activity and the chiral discriminations. Cambridge University Press, Cambridge
22. Harada N, Nakanishi K (1983) Circular dichroic spectroscopy: exciton coupling in organic stereochemistry. University Science Books, Mill Valley
23. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA et al (2003) Gaussian 03. Gaussian, Inc., Pittsburgh
24. Helgaker T, Jensen HJA, Joergensen P, Olsen J, Ruud K et al. (2001) DALTON, a molecular electronic structure program, v.1.2. http://www. daltonprogram.org/
25. Ahlrichs R, Bar M, Baron HP, Bauernschmitt R, Bocker S et al (2002) Turbomole v.5.6. Universitat Karlsruhe, Karlsruhe
26. PL Polavarapu 1997 Ab initio molecular optical rotations and absolute configurations Mol Phys 91 551 554 1:CAS:528:DyaK2sXktF2ntrw%3D
27. RK Kondru P Wipf DN Beratan 1998 Theory-assisted determination of absolute stereochemistry for complex natural products via computation of molar rotation angles J Am Chem Soc 120 2204 2205 10.1021/ja973690o 1:CAS:528:DyaK1cXhsFSgsr8%3D (Pubitemid 28179205)
28. Stephens PJ, Devlin FJ, Cheeseman JR, Frisch MJ (2001) Calculation of optical rotation using density functional theory. J Phys Chem A 105:5356-5371
29. PL Polavarapu 2002 Optical rotation: recent advances in determining the absolute configuration Chirality 14 768 781 10.1002/chir.10145 1:CAS:528:DC%2BD38Xos1aju7w%3D (Pubitemid 35253392)
30. C Diedrich S Grimme 2003 Systematic investigation of modern quantum chemical methods to predict electronic circular dichroism spectra J Phys Chem A 107 2524 2539 10.1021/jp0275802 1:CAS:528:DC%2BD3sXitFGntLs%3D
31. Pedersen TB, Koch H (2000) Theoretical electronic absorption and natural circular dichroism spectra of (-)-trans-cycloctene. J Chem Phys 112:2139
32. Furche F, Ahlrichs R, Wachsmann C, Weber E, Sobanski A et al (2000) Circular dichroism of helicenes investigated by time-dependent density functional theory. J Am Chem Soc 122:1717-1724
33. M Braun A Hohmann J Rahematpura C Buehne S Grimme 2004 Synthesis and determination of the absolute configuration of fugomycin and desoxyfugomycin: CD spectroscopy and fungicidal activity of butenolides Chem Eur J 10 4584 4593 10.1002/chem.200400132 1:CAS:528:DC%2BD2cXotFyqtL8%3D
34. TA Halgren 1996 Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 J Comput Chem 17 490 519 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P 1:CAS:528:DyaK28XhvVGmsbk%3D
35. Wavefunction Inc. (2002) SPARTAN '02. Wavefunction Inc., Irvine
36. Devlin FJ, Stephens PJ, Besse P (2005) Are the absolute configurations of 2-(1-hydroxyethyl)-chromen-4-one and its 6-bromo derivative determined by X-ray crystallography correct? A vibrational circular dichroism study of their acetate derivatives. Tetrahedron Asymmetr 16:1557-1566
37. Mason SF (1962) The absolute configuration of calycanthine. Proc Chem Soc 362-363
38. Harada N, Nakanishi K (1983) Circular dichroic spectroscopy-exciton coupling in organic stereochemistry. University Science Books, Mill Valley
39. N Harada K Nakanishi 1972 Exciton chirality method and its application to configurational and conformational studies of natural products Account Chem Res 5 257 263 10.1021/ar50056a001 1:CAS:528:DyaE38XltVSmtrY%3D
40. Salvadori P, Bertucci C, Rosini C, Zandomeneghi M, Gallo G, Martinelli E, Ferraris P (1972) Circular dichroism of rifamycin S. J Am Chem Soc 103:5553-5557
41. J Hodgson 2001 ADMET- turning chemicals into drugs Nat. Biotech. 19 722 726 10.1038/90761 1:CAS:528:DC%2BD3MXlsleksLc%3D (Pubitemid 32729533)
42. Peters T Jr (1996) All about albumin, biochemistry, genetics, and medical applications. Academic, New York
43. U Kragh-Hansen VTG Chuang M Otagiri 2002 Practical aspects of the ligand-binding and enzymatic properties of human serum albumin Biol Pharm Bull 25 695 704 10.1248/bpb.25.695 1:CAS:528:DC%2BD38XkvV2hu7s%3D (Pubitemid 40036701)
44. IW Wainer 1994 Enantioselective high-performance liquid affinity chromatography as a probe of ligand-biopolymer interactions: an overview of a different use for high-performance liquid chromatographic chiral stationary phases J Chromatogr A 666 221 234 10.1016/0021-9673(94)80384-6 1:CAS:528:DyaK2cXlslCitrg%3D (Pubitemid 24138214)
45. DS Hage 2002 High-performance affinity chromatography: a powerful tool for studying serum protein binding J Chromatogr B 768 3 30 10.1016/S0378- 4347(01)00482-0 1:CAS:528:DC%2BD38XhtVKhtbo%3D (Pubitemid 34142293)
46. C Bertucci E Domenici 2002 Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance Curr Med Chem 9 1463 1481 1:CAS:528:DC%2BD38Xlslyju7Y%3D
47. Ascoli GA, Domenici E, Bertucci C (2006) Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality 18:667-679
48. Bertucci C, Domenici E, Salvadori P (1990) Stereochemical features of 1,4-benzodiazepin-2-ones bound to human serum albumin: difference circular dichroism and UV studies. Chirality 2:167-174
49. G Ascoli C Bertucci P Salvadori 1995 Stereospecific and competitive binding of drugs to human serum albumin: a difference circular dichroism approach J Pharm Sci 84 737 741 10.1002/jps.2600840615 1:CAS:528: DyaK2MXlslykt7o%3D
50. M Pistolozzi C Bertucci 2008 Species-dependent stereoselective drug binding to albumin: a circular dichroism study Chirality 20 552 558 10.1002/chir.20521 1:CAS:528:DC%2BD1cXis12hu7c%3D (Pubitemid 351303995)
51. K Kaneko H Fukuda VT Chuang K Yamasaki K Kawahara H Nakayama A Suenaga T Maruyama M Otagiri 2008 Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin Drug Metab Dispos 36 1 81 86 10.1124/dmd.107.016873 1:CAS:528:DC%2BD1cXmtFGksA%3D%3D
52. G Sudlow DJ Birkett DN Wade 1975 The characterization of two specific drug binding sites on human serum albumin Mol Pharmacol 11 824 832 1:CAS:528:DyaE28XmvFahsQ%3D%3D
53. A Robertson W Karp R Brodersen 1990 Comparison of the binding characteristic of serum albumins from various animal species Dev Pharmacol Ther 15 106 111 1:CAS:528:DyaK3MXhvFyqu7k%3D
54. T Kosa T Maruyama N Sakai N Yonemura S Yahara M Otagiri 1998 Species difference of serum albumins: III. Analysis of structural characteristics and ligand binding properties during N-B transitions Pharm. Res. 15 592 598 10.1023/A:1011986028529 1:CAS:528:DyaK1cXjt1akt74%3D (Pubitemid 28214953)
55. I Fitos J Visy M Simonyi 2002 Species-dependency in chiral-drug recognition of serum albumin studied by chromatographic methods J Biochem Biophys Methods 54 71 84 10.1016/S0165-022X(02)00131-8 1:CAS:528: DC%2BD3sXltlahtQ%3D%3D (Pubitemid 36126136)
56. M Dockal DC Carter F Ruker 1999 The three recombinant domains of human serum albumin J Biol Chem 41 29303 29310 10.1074/jbc.274.41.29303 (Pubitemid 29477098)
57. G Massolini E De Lorenzi MC Ponci G Caccialanza 1996 Comparison of drug binding sites on rat and human serum albumins using immobilized-protein stationary phases as a tool for the selection of suitable animal models in pharmacological studies Boll Chim Farm 135 382 386 1:CAS:528:DyaK28XnsFSjt7w%3D
58. G Massolini AF Aubry A McGann IW Wainer 1993 Determination of the magnitude and enantioselectivity of ligand binding to rat and rabbit serum albumins using immobilized-protein high performance liquid chromatography stationary phases Biochem Pharmacol 46 1285 1293 10.1016/0006-2952(93)90478-F 1:CAS:528:DyaK2cXksFSlsA%3D%3D (Pubitemid 23306750)
59. M Zandomeneghi 1995 Circular dichroism of ketoprofen complexed to serum albumins: conformational selection by the protein: a novel optical purity determination technique Chirality 7 446 451 10.1002/chir.530070610 1:CAS:528:DyaK2MXovVKqur0%3D
60. V Ghislandi A La Manna O Azzolina A Gazzaniga D Vercesi 1982 Configurational relationships in antiphogistic hydratropic acids Farmaco 37 81 93 1:CAS:528:DyaL38XhvFyksbY%3D
61. DA Lightner WM Wijekoon MH Zhang 1988 Understanding bilirubin conformation and binding. Circular dichroism of human serum albumin complexes with bilirubin and its esters J Biol Chem 263 16669 16676 1:CAS:528: DyaL1cXmt1Gjt78%3D
62. CE Petersen C-E Ha K Harohalli JB Feix NV Bhagavan 2000 A dynamic model for bilirubin binding to human serum albumin J Biol Chem 275 20985 20995 10.1074/jbc.M001038200 1:CAS:528:DC%2BD3cXkvFGjt7s%3D (Pubitemid 30481786)
63. SE Boiadjiev DA Lightner 1997 Exciton chirality of bilirubin homologs Chirality 9 604 615 10.1002/(SICI)1520-636X(1997)9:5/6<604::AID-CHIR31>3. 0.CO;2-Q 1:CAS:528:DyaK2sXmsFakurY%3D (Pubitemid 27430455)
64. C Bertucci A Viegi G Ascoli P Salvadori 1995 Protein binding investigation by difference circular dichroism: native and acetylated human serum albumin Chirality 7 57 61 10.1002/chir.530070202 1:CAS:528: DyaK2MXkvFSqurk%3D
65. C Bertucci B Nanni P Salvadori 1999 Reversible binding of ethacrynic acid to human serum albumin: difference circular dichroism study Chirality 11 33 38 10.1002/(SICI)1520-636X(1999)11:1<33::AID-CHIR6>3.0.CO;2-U 1:CAS:528:DyaK1MXjt1Kh (Pubitemid 29016329)
66. SM Kelly NC Price 2000 The use of circular dichroism in the investigation of protein structure and function Curr Protein Pept Sci 1 4 349 384 10.2174/1389203003381315 1:CAS:528:DC%2BD3MXns1ehtw%3D%3D
67. G Siligardi R Hussain 1998 Biomolecules interactions and competitions by non-immobilised ligand interaction assay by circular dichroism Enantiomer 3 2 77 87 1:CAS:528:DyaK1cXms1Crsr0%3D
68. DJ Rodi JRW DJ HJ Sanganee RA Holton BA Fallace L Makowski 1999 Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein J Mol Biol 285 197 203 10.1006/jmbi.1998.2303 1:CAS:528:DyaK1MXntFCrtA%3D%3D (Pubitemid 29034037)
69. HN Chua L Wong 2008 Increasing the reliability of protein interactomes Drug Discov Today 13 15/16 652 658 10.1016/j.drudis.2008.05.004 1:CAS:528:DC%2BD1cXpsValsr4%3D
70. S Fields O Song 1989 A novel genetic system to detect protein-protein interactions Nature 340 245 246 10.1038/340245a0 1:CAS:528:DyaL1MXltlShsL8%3D (Pubitemid 19171591)
71. El-Samalouti VT, Schletter J, Brade H, Brade L, Kusumoto S, Rietschel ET, Flad HD, Ulmer AJ (1997) Detection of lipopolysaccharide (LPS)-binding membrane proteins by immuno-coprecipitation with LPS and anti-LPS antibodies. Eur J Biochem 250:418-424
72. I Roman J Figys G Steurs M Zizi 2006 Direct measurement of VDAC-actin interaction by surface plasmon resonance Biochim Biophys Acta 1758 479 486 10.1016/j.bbamem.2006.03.019 1:CAS:528:DC%2BD28XltFCrsbk%3D (Pubitemid 43767729)
73. B Royer-Zemmour M Ponsole-Lenfant H Gara P Roll C Leveque A Massacrier G Ferracci J Cillario A Robaglia-Schlupp R Vincentelli P Cau P Szepetowski 2008 Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR Hum Mol Genet 17 23 3617 3630 10.1093/hmg/ddn256 1:CAS:528:DC%2BD1cXhtlGis7%2FN
74. JL Ortega-Roldan M Ringkjøbing Jensen B Brutscher AI Azuaga M Blackledge NAJ van Nuland 2009 Accurate characterization of weak macromolecular interactions by titration of NMR residual dipolar couplings: application to the CD2AP SH3-C:ubiquitin complex Nucleic Acids Res 37 9 1 12 10.1093/nar/gkp211
75. Park S, Lim BBC, Perez-Terzic C, Mer G, Terzic A (2008) Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity. J Proteome Res 7(4):1721-1728
76. Downard KM (2006) Ions of the interactome: the role of MS in the study of protein interactions in proteomics and structural biology. Proteomics 6:5374-5384
77. Martin S, Roe D, Faulon JL (2005) Predicting protein-protein interactions using signature products. Bioinformatics 21:218-226
78. Saito R, Suzuki H, Hayashizaki Y (2003) Construction of reliable protein-protein interaction networks with a new interaction generality measure. Bioinformatics 19:756-763
79. J Chen W Hsu ML Lee SK Ng 2006 Increasing confidence of protein interactomes using network topological metrics Bioinformatics 22 1998 2004 10.1093/bioinformatics/btl335 1:CAS:528:DC%2BD28Xotl2qtrk%3D (Pubitemid 44283012)
80. CA Ross MA Poirier 2004 Protein aggregation and neurodegenerative disease Nat Med 10 Suppl S10 S17 10.1038/nm1066 (Pubitemid 38901862)
81. CJ Barrow MG Zagorski 1991 Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition Science 253 179 182 10.1126/science.1853202 1:CAS:528:DyaK3MXlsFegsLo%3D
82. Barrow CJ, Yasuda A, Kenny PT, Zagorski MG (1992) Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease: analysis of circular dichroism spectra. J Mol Biol 225:1075-1093
83. L Otvos GI Szendrei VM Lee HH Mantsch 1993 Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents Eur J Biochem 211 249 257 10.1111/j.1432-1033.1993.tb19893.x 1:CAS:528:DyaK3sXhs1Kmur0%3D (Pubitemid 23039520)
84. Tomaselli S, Esposito V, Vangone P, van Nuland NAJ, Bonvin AMJJ, Guerrini R, Tancredi T, Temessi PA, Picone D (2006) The α to β conformational transition of Alzheimer's Aβ-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of β conformation seeding. Chembiochem 7:257-267
85. Fezoui Y, Teplow DB (2002) Kinetic studies of amyloid β-protein fibril assembly: differential effects of α-helix stabilization. J Biol Chem 277:36948-36954
86. Bartolini M, Bertucci C, Bolognesi ML, Cavalli A, Melchiorre C, Andrisano V (2007) Insight into the kinetics of amyloid β (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action. Chembiochem 8:2152-2161
87. Bartolini M, Bertucci C, Cavrini V, Andrisano V (2003) Beta-amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol 65:407-416
88. Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB (1996) On the nucleation and growth of amyloid b-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci USA 93:1125-1129
89. Pai A, Rubinstein I, Onyuksel H (2006) PEGylated phospholipid nanomicelles interact with beta-amyloid(1-42) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro. Peptides 27:2858-2866
90. SS Wang YT Chen SW Chou 2005 Inhibition of amyloid fibril formation of beta-amyloid peptides via the amphiphilic surfactants Biochim Biophys Acta Mol Basis Dis 1741 307 313 1:CAS:528:DC%2BD2MXhtVegurjI
91. Inouye H, Fraser PE, Kirschner DA (1993) Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by X-ray diffraction. Biophys J 64:502-519
92. Fraser PE, McLachlan DP, Surewicz WK, Mizzen CA, Snow AD, Nguyen JT, Kirschner DA (1994) Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues. J Mol Biol 244:64-73
93. JD Harper SS Wong CM Lieber PT Lansbury Jr 1997 Observation of metastable Abeta amyloid protofibrils by atomic force microscopy Chem Biol 4 119 125 10.1016/S1074-5521(97)90255-6 1:CAS:528:DyaK2sXitVynsL8%3D
94. DB Teplow 1998 Structural and kinetic features of amyloid beta-protein fibrillogenesis Amyloid 5 121 142 1:CAS:528:DyaK1cXkvVensLw%3D
95. M Sunde C Blake 1997 The structure of amyloid fibrils by electron microscopy and X-ray diffraction Adv Protein Chem 50 123 159 10.1016/S0065-3233(08)60320-4 1:CAS:528:DyaK2sXotVyktrg%3D (Pubitemid 27449487)
96. G Campadelli-Fiume M Amasio E Avitabile A Cerretani C Forghieri T Gianni L Menotti 2007 The multipartite system that mediates entry of herpes simplex virus into the cell Rev Med Virol 17 5 313 326 10.1002/rmv.546 1:CAS:528:DC%2BD2sXhtFKntL3P (Pubitemid 47425869)
97. T Gianni A Piccoli C Bertucci G Campadelli-Fiume 2006 Heptad repeat 2 in herpes simplex virus 1 gH interacts with heptad repeat 1 and is critical for virus entry and fusion J Virol 80 2216 2224 10.1128/JVI.80.5.2216-2224.2006 1:CAS:528:DC%2BD28XhvFyhtr0%3D (Pubitemid 43271528)
98. B Sanavio A Piccoli T Gianni C Bertucci 2007 Helicity propensity and interaction of synthetic peptides from heptad-repeat domains of herpes simplex virus 1 glycoprotein H: a circular dichroism study Biochim Biophys Acta 1774 7 781 791 1:CAS:528:DC%2BD2sXntFKhsb8%3D
99. S Liu G Xiao Y Chen Y He J Niu CR Escalante H Xiong J Farmar AK Debnath P Tien S Jiang 2004 Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors Lancet 363 938 947 10.1016/S0140-6736(04)15788-7 1:CAS:528:DC%2BD2cXisVSktbo%3D (Pubitemid 38388327)
100. B Tripet MW Howard M Jobling RK Holmes KV Holmes RS Hodges 2004 Structural characterization of the SARS-coronavirus spike S fusion protein core J Biol Chem 279 20836 20849 10.1074/jbc.M400759200 1:CAS:528: DC%2BD2cXjvV2nsL8%3D (Pubitemid 38656480)
101. F Quadrifoglio DW Urry 1967 Circular dichroism and optical rotatory dispersion of gramicidin S in aqueous solution Biochem Biophys Res Commun 29 6 785 791 10.1016/0006-291X(67)90288-4 1:CAS:528:DyaF1cXks1aktw%3D%3D
102. S Beychok E Breslov 1968 Circular dichroism of oxytocin and several oxytocin analogues J Biol Chem 243 1 151 154 1:CAS:528:DyaF1cXislemtA%3D%3D
103. Y Sadhale JC Shah 1999 Stabilization of insulin against agitation-induced aggregation by the GMO cubic phase gel Int J Pharm 191 51 64 10.1016/S0378-5173(99)00288-4 1:CAS:528:DyaK1MXotVGjsLw%3D (Pubitemid 29502177)
104. Hudson FM, Handersen NH (2004) Exenatide: NMR/CD evaluation of the medium dependence of conformation and aggregation state. Biopolymers 76:298-308
105. Taschner N, Müller SA, Alumella VR, Goldie KN, Drake AF, Aebi U, Arvinte T (2001) Modulation of antigenicity related to changes in antibody flexibility upon lyophilization. J Mol Biol 310:169-179
106. MD Bruch Y Cajal JT Koh MK Jain 1999 Higher-order structure of Polymixin B: the functional significance of topological flexibility J Am Chem Soc 121 11993 12004 10.1021/ja992376m 1:CAS:528:DyaK1MXnvVCmtb4%3D (Pubitemid 30027775)
107. S Konno JW Fenton GB Villanueva 1988 Analysis of the secondary structure of hirudin and the mechanism of its interaction with thrombin Arch Biochem Biophys 267 158 166 10.1016/0003-9861(88)90019-7 1:CAS:528:DyaL1MXitVChsQ%3D%3D (Pubitemid 19001020)
108. K liger Y, Shai Y (2000) Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation. J Mol Biol 295:163-168
109. Arvinte T, Bui TTT, Dahab AA, Demeule B, Drake AF, Elhag D, King P (2004) The multi-mode polarization modulation spectrometer. Part 1: simultaneous detection of absorption, turbidity, and optical activity. Anal Biochem 332:46-57
110. Demeule B, Lawrence MJ, Drake AF, Gurny R, Arvinte T (2006) Characterization of protein aggregation: the case of a therapeutic immunoglobulin. Biochim Biophys Acta 1774(1):146-153
111. N Keegan NG Wright JH Lakey 2005 Circular dichroism spectroscopy of folding in a protein monolayer Angew Chem 117 4879 4882 10.1002/ange.200462977